DeltaScan
Clinical Study Data
Quick navigation: Clinical Benefit Studies - Validation Studies
Cardiac Surgery
![Patients](https://prolira.com/hubfs/Naamloze%20presentatie%20(15).png)
903
Patients
![mst-delirium-qi-program](https://prolira.com/hubfs/mst-delirium-qi-program.png)
Cardiac Surgery
![Patients](https://prolira.com/hubfs/Naamloze%20presentatie%20(15).png)
850
Patients
![hdz-delirium-management-improvement](https://prolira.com/hubfs/hdz-delirium-management-improvement.png)
By implementing a delirium reduction program, including DeltaScan, delirium incidence was reduced from 25% to 8%. Resulting in a cost savings of several million euros.
As presented during webinar on February 21, 2024
Proof of concept study
![Patients](https://prolira.com/hubfs/Naamloze%20presentatie%20(15).png)
56
Patients
![Technical Proof Study Prolira Deltascan](https://prolira.com/hubfs/Technical%20Proof%20Study%20Prolira%20Deltascan-1.png)
Validation study
![Patients](https://prolira.com/hubfs/Naamloze%20presentatie%20(15).png)
145
Patients
321 EEGs
![Validation Study EEG Acute Encephalopathy](https://prolira.com/hubfs/Validation%20Study%20EEG%20Acute%20Encephalopathy.png)
Interested? Let's get in touch!
Get in touch to learn how you can reshape acute encephalopathy and delirium care delivery.
pageversion: 4.0